1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 5.3K | 38.77% |
| Gross profit | 12.01K | 139.17% |
| Net profit | -211.41K | 15.54% |
| EBITDA | -231.33K | 18.85% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €5.37M |
Number of shares | 313.98M |
52-week high/low | €0.0255 - €0.0131 |
| Dividends | No |
Beta | 1.74 |
P/E ratio | -4.95 |
PEG ratio | -0.19 |
P/B ratio | 1.89 |
P/S ratio | 189.83 |
Company profile
XP Chemistries AB, ein Biotechnologieunternehmen, entwickelt und produziert Capsaicin und Analoga auf Waldbasis. Es bietet Futtermittelzutaten, kosmetische Inhaltsstoffe, reine Capsaicinoide sowie Selbstverteidigungsflüssigkeiten und -zutaten an. Das Unternehmen wurde 2018 gegründet und hat seinen Sitz in Sundsvall, Schweden.
| Name | XP CHEMISTRIES AB Aktie |
| CEO | Erik Nelsson |
| Headquarters | Sundsvall,
vn Sweden |
| Website | |
| IPO | 10/29/2021 |
| Employees | 2 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Sto | XPC.ST |
Frankfurt | 86Q.F |
Stockholm | XPC.ST |
München | 86Q.MU |
